Article

ApoE-deficient mice on cholate-containing high-fat diet reveal a pathology similar to lung sarcoidosis.

Department of Oral Science, Faculty of Dentistry, 2350 Health Sciences Mall, Life Sciences Institute, Room 4559, University of British Columbia, Vancouver V6T 1Z3, Canada.
American Journal Of Pathology (Impact Factor: 4.6). 03/2010; 176(3):1148-56. DOI: 10.2353/ajpath.2010.090857
Source: PubMed

ABSTRACT Sarcoidosis is a chronic disease of unknown etiology characterized by the formation of non-necrotizing epithelioid granulomas in various organs, especially in the lungs. The lack of an adequate animal model reflecting the pathogenesis of the human disease is one of the major impediments in studying sarcoidosis. In this report, we describe ApoE-/- mice on a cholate-containing high-fat diet that exhibit granulomatous lung inflammation similar to human sarcoidosis. Histological analysis revealed well-defined and non-necrotizing granulomas in about 40% of mice with the highest number of granulomas after 16 weeks on a cholate-containing high-fat diet. Granulomas contained CD4+ and CD8+ T cells, and the majority of the cells in granulomas showed immunoreactivity for the macrophage marker Mac-3. Cells with morphological features of epithelioid cells expressed angiotensin-converting enzyme, osteopontin, and cathepsin K, all characteristics of epithelioid and giant cells in granulomas of human sarcoidosis. Giant cells and nonspecific inclusions such as Schaumann's bodies and crystalline deposits were also detected in some lungs. Granulomatous inflammation resulted in progressive pulmonary fibrosis. Removal of cholate from the diet prevented the formation of lung granulomas. The observed similarities between the analyzed mouse lung granulomas and granulomas of human sarcoidosis, as well as the chronic disease character leading to fibrosis, suggest that this mouse model might be a useful tool to study sarcoidosis.

0 Bookmarks
 · 
180 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lack of animal models with human-like size and pathology hampers translational research in atherosclerosis. Mouse models are missing central features of human atherosclerosis and are too small for intravascular procedures and imaging. Modeling the disease in minipigs may overcome these limitations, but it has proven difficult to induce rapid atherosclerosis in normal pigs by high-fat feeding alone, and genetically modified models similar to those created in mice are not available. D374Y gain-of-function mutations in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene cause severe autosomal dominant hypercholesterolemia and accelerates atherosclerosis in humans. Using Sleeping Beauty DNA transposition and cloning by somatic cell nuclear transfer, we created Yucatan minipigs with liver-specific expression of human D374Y-PCSK9. D374Y-PCSK9 transgenic pigs displayed reduced hepatic low-density lipoprotein (LDL) receptor levels, impaired LDL clearance, severe hypercholesterolemia, and spontaneous development of progressive atherosclerotic lesions that could be visualized by noninvasive imaging. This model should prove useful for several types of translational research in atherosclerosis.
    Science translational medicine 01/2013; 5(166):166ra1. DOI:10.1126/scitranslmed.3004853 · 14.41 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rationale: Although lipids, apolipoproteins and lipoprotein particles are important modulators of inflammation, varying relationships exist between these parameters and asthma. Objectives: To determine whether serum lipids and apolipoproteins correlate with the severity of airflow obstruction in atopic asthmatics. Methods: Serum samples were obtained from 154 atopic and non-atopic non-asthmatics, and 159 atopic asthmatics. Serum lipid and lipoprotein levels were quantified, using standard diagnostic assays and nuclear magnetic resonance (NMR) spectroscopy. Airflow obstruction was assessed by % predicted forced expiratory volume in 1 second (FEV1). Measurements and Main Results: Serum lipid levels correlated with FEV1 only in the atopic asthmatic group. Serum levels of HDL cholesterol (HDL-C) and apolipoprotein A-I (apoA-I) were positively correlated with FEV1 in atopic asthmatics, whereas a negative correlation existed between FEV1 and serum levels of triglycerides (TG), LDL cholesterol (LDL-C), apolipoprotein B (apoB) and the apoB/apoA-I ratio. NMR spectroscopy identified a positive correlation between FEV1 and HDLNMR particle size, as well as the concentrations of large HDLNMR particles and total IDLNMR (intermediate-density lipoprotein) particles in atopic asthmatics. In contrast, LDLNMR particle size and concentrations of LDLNMR and VLDLNMR (very low density lipoprotein) particles were negatively correlated with FEV1 in atopic asthmatics. Conclusions: In atopic asthmatics, serum levels of apoA-I and large HDLNMR particles are positively correlated with FEV1, whereas serum TG, LDL-C and apoB are associated with more severe airflow obstruction. These results may facilitate future studies to assess whether apoA-I and large HDLNMR particles can reduce airflow obstruction and disease severity in asthma.
    American Journal of Respiratory and Critical Care Medicine 02/2015; DOI:10.1164/rccm.201411-1990OC · 11.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Interstitial lung disease (ILD) is a well-known adverse effect of mammalian target of rapamycin (mTOR) inhibitors. However, it remains unknown how lung toxicities are induced by mTOR inhibitors. Here, we constructed a mouse model of mTOR inhibitor-induced ILD using temsirolimus and examined the pathogenesis of the disease. Male ICR mice were treated by intraperitoneal injection of different doses of temsirolimus (3 mg/kg/week or 30 mg/kg/week) or vehicle. Temsirolimus treatment increased capillary-alveolar permeability and induced neutrophil infiltration and fibrinous exudate into the alveolar space, indicating alveolar epithelial and/or endothelial injury. It also induced macrophage depletion and accumulation of excessive surfactant phospholipids and cholesterols. Alveolar macrophage depletion is thought to cause surfactant lipid accumulation. To further examine whether temsirolimus has a cytotoxic and/or cytostatic effects on alveolar macrophages and alveolar epithelial cells, we performed in vitro experiments. Temsirolimus inhibited cell proliferation and viability in both alveolar macrophage and alveolar epithelial cells. Temsirolimus treatment caused some signs of pulmonary inflammation, including upregulated expression of several proinflammatory cytokines in both bronchoalveolar lavage cells and lung homogenates, and an increase in lymphocytes in the bronchoalveolar lavage fluid. These findings indicate that temsirolimus has the potential to induce alveolar epithelial injury and to deplete alveolar macrophages followed by surfactant lipid accumulation, resulting in pulmonary inflammation. This is the first study to focus on the pathogenesis of mTOR inhibitor-induced ILD using an animal model.
    AJP Lung Cellular and Molecular Physiology 05/2014; 306(12). DOI:10.1152/ajplung.00251.2013 · 3.52 Impact Factor

Full-text (2 Sources)

Download
22 Downloads
Available from
Jul 4, 2014